Analysis of psychoemotional state and intellectual abilities in patients with asthma and chronic obstructive pulmonary disease - Preliminary results

Psychiatria Danubina

Volumn 25, Issue SUPPL.2, 2013, Pages

  Bratek, Agnieszka ^a   Zawada, Karolina ^a   Barczyk, Adam ^a   Sozańska, Ewa ^a   Krysta, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Anxiety; Asthma; Cognitive functions; COPD; Depression

Indexed keywords

ADULT; AGED; ASTHMA; BECK DEPRESSION INVENTORY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EMOTIONAL STABILITY; HUMAN; INTELLIGENCE; MENTAL DISEASE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; PATIENT COMPLIANCE; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; SPIROMETRY; SPUTUM; STATE TRAIT ANXIETY INVENTORY;

EID: 84892383585     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ et al.: Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005; 90:2522-30.
2. Beck AT, Ward CH, Mendelson M, Mock J & Erbaugh J: An Inventory for Measuring Depression. Arch Gen Psychiat 1961; 4:561-71.
3. Brenes GA: Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003; 65:963-970.
4. Brown ES, Vera E, Frol AB, Woolston DJ & Johnson B: Effects of chronic prednisone therapy on mood and memory. J Affect Disord 2007; 99: 279-83.
5. Brown ES: Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 2009; 1179:41-55.
6. Carvalho NS, Ribeiro PR, Ribeiro M, Nunes Mdo P, Cukier A & Stelmach R: Comparing asthma and chronic obstructive pulmonary disease in terms of symptoms of anxiety and depression. J Bras Pneumol 2007; 33:1-6.
7. Corrigan JD & Hinkeldey MS: Relationships between Parts A and B of the Trail Making Test. J Clinical Psychology 1987; 43:402-9.
8. Dodd JW, Getov SV & Jones PW: Cognitive function in COPD. Eur Respir J 2010; 35:913-22.
9. Ford DE & Erlinger TP: Depression and C-reactive protein in US adults. Arch Intern Med 2004; 164:1010-4.
10. Goodwin RD, Fergusson DM & Horwood LJ: Asthma and depressive and anxiety disorders among young persons in the community. Psychol Med 2004; 34:1465-74.
11. Katon WJ, Richardson L, Lozano P & McCauley E: The relationship of asthma and anxiety disorders. Psychosom Med 2004; 66:349-55.
12. Kim LL, Simon BL, Barone S, Cartier A, Ditto B & Labrecque M: What is worse for asthma control and quality of life depressive disorders, anxiety disorders, or both? Chest 2006; 130:1039-47.
13. Krishnadas R & Cavanagh J: Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 2012; 83:495-502.
14. Lavoie KL, Cartier A, Labrecque M, Bacon SL, Lemière C, Malo JL et al.: B: Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients? Rev Bras Psiquiatr 2006; 28:206-8.
15. Maes M: Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461:25-46.
16. Mikkelsen RL, Middelboe T, Pisinger C & Stage K: Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58:65.
17. Nascimento I, Nardi AE, Valença AM, Lopes FL, Mezzasalma MA, Nascentes R et al.: Psychiatric disorders in asthmatic outpatients. Psychiatry Res 2002; 110:73-80.
18. Raison CL, Capuron L & Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27:24-3.
19. Richardson LP, Lozano P, Russo J, McCauley E, Bush T & Katon W: Asthma symptom burden: relationship to asthma severity and anxiety and depression symptoms. Pediatrics 2006; 118:1042-51.
20. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L et al.: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30:208-25.
21. Słuzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M & Wiktorowicz K: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 1995; 762:474-6.
22. Spielberger CD: Manual for the State-Trait Anxiety Inventory STAI (Form Y) ("Self Evaluation Questionnaire") Palo Alto: Consulting Psychologists Press, Inc, 1983.
23. Thomas M, Bruton A, Moffat M & Cleland J: Asthma and psychological dysfunction. Prim Care Respir J 2011; 20:250-6.
24. Valença AM, Falcão R, Freire RC, Nascimento I, Nascentes R, Zin WA et al.: The relationship between the severity of asthma and comorbidities with anxiety and depressive disorders. Respir Med 2005; 99:1249-57.
25. Van Lieshout RJ & Macqueen G: Psychological factors in asthma. Allergy Asthma Clin Immunol 2008; 4:12-28.
26. Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD & Ruffin RE: Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 1987; 146:305.
27. Yohannes AM, Baldwin R & Connolly MJ: Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15:1090-6.
28. Zawada K, Bratek A & Barczyk A: Analiza zaburzeń funkcji poznawczych nasilenia lêku i depresji u chorych z astma̧, przewlekła̧ obturacyjna̧ choroba̧ płuc oraz zespołem nakładania astmy i POChP. Pneumonol Alerg Pol 2013a; 81: Suppl 1:1.
29. Zawada K, Burzynska-Kozmin A & Krysta K: 2779 - Patients with obesity hypoventilation syndrome and mental disorders. Eur Psychiatry 2013b; 28: Suppl 1:1.